JPRN-jRCT2080220794未知2 期
A Phase 2a A Study of TAC-201 An Cedar pollen Antigen-challenged Study in an Environmental Exposure Chamber
试验速览
- 阶段
- 2 期
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 55age old（—）
- 性别
- All
入选标准
- •Distinct symptoms of Japanese cedar pollinosis during the cedar pollen allergy season in 2009, with the severity of moderate or higher
排除标准
- •Previous participation in the study of TAC-201
研究者
相似试验
未知
2 期
A POC Study of TAC-201Cedar pollen allergyJPRN-jRCT2080221355Taiho Pharmaceutical Co., Ltd.96
进行中（未招募）
1 期
A phase II study to assess the efficacy of the antibody atezolizumab administered with stereotactic ablative radiotherapy in patients with metastatic cancerEUCTR2015-005464-42-ESGustave Roussy180
进行中（未招募）
不适用
A Phase 2a Study of Ataluren (PTC124) in Nonambulatory Patients with Nonsense–Mutation-Mediated Duchenne/Becker Muscular Dystrophy - Study of Ataluren in Nonambulatory Patients with DMD/BMDEUCTR2009-013169-24-GBPTC Therapeutics Inc30
已完成
2 期
ATTAXACTRN12606000163505Australasian Gastro-Intestinal Trials Group A(AGITG)100
已完成
3 期
A Phase 3 Extension Study of Ataluren (PTC124) in Subjects with Nonsense-Mutation-Mediated Cystic Fibrosis100386861001567410006436Cystic FibrosisNL-OMON36381PTC Therapeutics, Inc.10